BETH C SEIDENBERG Transaction History

Date Transaction Value Shares Traded Form
May 09 2023
BUY
Open market or private purchase
$22,500,000 $18.0 p/Share
1,250,000
May 09 2023
BUY
Conversion of derivative security
-
8,540,729

Also insider at

PGNY
Progyny, Inc. Healthcare
VERA
Vera Therapeutics, Inc. Healthcare
ATRA
Atara Biotherapeutics, Inc. Healthcare
SGMT
Sagimet Biosciences Inc.
KYTX
Kyverna Therapeutics, Inc.
BCS

Beth C Seidenberg

Director
New York, NY

Track Institutional and Insider Activities on SLRN

Follow ACELYRIN, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SLRN shares.

Notify only if

Insider Trading

Get notified when an Acelyrin, Inc. insider buys or sells SLRN shares.

Notify only if

News

Receive news related to ACELYRIN, Inc.

Track Activities on SLRN